Notify me when Velan Capital Investment Management LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| EDSA | Edesa Biotech, Inc. | Common Shares, without par value | 10% | $1,595,167 | 693,551 | Velan Capital Investment Management LP | 12 Feb 2025 | ||
| JSPR | Jasper Therapeutics, Inc. | Voting Common Stock, par value $0.0001 per share | 9.6% | $7,578,242 | 2,668,395 | Velan Capital Investment Management LP | 19 Sep 2025 | ||
| NSPR | InspireMD, Inc. | Common Stock, par value $0.0001 per share | 5.1% | $5,209,186 | 2,143,698 | Velan Capital Master Fund LP | 30 Jul 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|